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Biochemical characterization of rolledSem, an activated form of
Drosophila mitogen-activated protein kinase
Abstract
The rolled (rl) gene of Drosophila encodes a homologue of vertebrate mitogen-activated protein kinases.
Genetic analyses have shown that the gain-of-function mutation rolledSevenmaker (rlSem) is sufficient
to activate developmental pathways controlled by distinct receptor tyrosine kinases, such as Sevenless,
Torso, and the Drosophila epidermal growth factor receptor homologue. Here we show that mutant
RlSem protein, immunoprecipitated from transiently transfected COS cells, exhibits a moderate increase
in kinase activity compared with wild-type Rl protein. Time course studies revealed that RlSem is more
active than Rl following short term as well as prolonged treatment with epidermal growth factor.
Interestingly, a more pronounced difference in kinase activity is observed when the proteins are
immunoprecipitated from extracts of Drosophila rl and rlSem larvae. In fact, the kinase activity of
RlSem from larvae extracts is comparable to the kinase activity of larvae expressing either an activated
Sevenless receptor or an activated Raf kinase. We also demonstrate that Dsor1, which has been placed
upstream of rl genetically, is able to phosphorylate and activate Rl in vitro.
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The rolled (rl) gene of Drosophila encodes a homo-
logue of vertebrate mitogen-activated protein kinases.
Genetic analyses have shown that the gain-of-function
mutation rolledSevenmaker (rlSem) is sufficient to activate
developmental pathways controlled by distinct receptor
tyrosine kinases, such as Sevenless, Torso, and the Dro-
sophila epidermal growth factor receptor homologue.
Here we show that mutant RlSem protein, immunopre-
cipitated from transiently transfected COS cells, exhib-
its a moderate increase in kinase activity compared
with wild-type Rl protein. Time course studies revealed
that RlSem is more active than Rl following short term as
well as prolonged treatment with epidermal growth fac-
tor. Interestingly, a more pronounced difference in ki-
nase activity is observed when the proteins are immu-
noprecipitated from extracts of Drosophila rl and rlSem
larvae. In fact, the kinase activity of RlSem from larvae
extracts is comparable to the kinase activity of larvae
expressing either an activated Sevenless receptor or an
activated Raf kinase. We also demonstrate that Dsor1,
which has been placed upstream of rl genetically, is able
to phosphorylate and activate Rl in vitro.
The mitogen-activated protein kinase (MAPK)1 cascade is a
major signaling system by which cells translate extracellular
signals into intracellular responses. The mammalian extracel-
lular signal-regulated kinases (ERKs) are the best studied
members of the MAP kinase family (for reviews, see Refs. 1 and
2). They are activated by phosphorylation on threonine and
tyrosine residues by dual specificity MAPK kinases (MAPKKs).
On activation, MAP kinases translocate to the nucleus (3) and
activate transcription factors through phosphorylation of ser-
ine or threonine residues in the motif P/LXT/SP. One of the
best characterized target proteins of MAPK is the ternary
complex factor ELK-1, which is phosphorylated by MAP ki-
nases in vitro on sites essential for trans-activation by the
serum response element on the c-fos promotor in vivo (4, 5).
Many steps of the MAP kinase cascade are conserved in
different species, and homologous components have been iden-
tified in mammals, yeast, Drosophila melanogaster, and Cae-
norhabditis elegans. In Drosophila, for example, the specifica-
tion of the R7 photoreceptor cell fate in each ommatidium of the
developing eye is dependent on the components of the MAP
kinase cascade. In the R7 precursor cells the Sevenless (Sev)
receptor tyrosine kinase is activated by its ligand, the Bride-
of-sevenless (Boss) protein. The signal is then transduced via
Drk (an SH3-SH2-SH3 adaptor protein, homologous to Grb2),
Sos, Ras1, and the protein kinases Raf, Dsor1 (MAPKK), and
Rl (MAPK) to the nucleus (reviewed in Refs. 6 and 7). A gain-
of-function mutation in the rl gene, rlSem, was identified in a
genetic screen for dominant mutations that result in the spec-
ification of R7 cells in the absence of the inducing signal, the
Boss ligand. This dominant mutation is caused by a single
amino acid substitution (D334N) in the catalytic domain of the
kinase (8). Interestingly, this mutation not only activates the
Sev pathway in the developing eye but also induces the forma-
tion of additional wing veins and causes female sterility mim-
icking the activation of the Drosophila EGF receptor homo-
logue (DER) and Torso receptor tyrosine kinases, respectively.
Therefore, Rl function is not only necessary but also sufficient
to activate multiple receptor tyrosine kinase pathways in Dro-
sophila. The homologue of the MAP kinase activating kinase
(MAPKK) encoded by the Dsor1 gene is also required for mul-
tiple developmental pathways (9). Using a temperature-sensi-
tive mutation in Dsor1, Hsu and Perrimon (10) showed that
Dsor1 operates like rl in the pathways controlled by Torso,
DER, and Sev.
Two nuclear target genes have been shown genetically to act
downstream of rl in the Sev pathway, pointed P2 (pntP2) and
yan, encoding two members of the ETS family of transcription
factors (11, 12). Furthermore, it has been shown that wild-type
Rl directly phosphorylates Yan and PntP2 in vitro (11).
The ordering of the individual components in the Sev path-
way has been determined largely by constructing double mu-
tants of different members of the cascade to examine epistatic
relationships between the different gene products. Although
this type of genetic analysis allows ordering of individual com-
ponents by functional criteria, it does not imply direct physical
interactions, nor does it reveal the biochemical mechanisms by
which the signals are transduced. To investigate the biochem-
ical properties of the first identified gain-of-function mutation
in a MAP kinase gene, rlSem, we examined the kinase activity
of the corresponding mutant protein, immunoprecipitated from
transfected COS cell lysates and Drosophila larvae extracts.
We demonstrate that RlSem, expressed in mammalian COS
cells or purified from bacteria, is 2–3-fold more active than
wild-type Rl. However, when isolated from Drosophila larvae,
RlSem exhibited a 5–9-fold higher kinase activity than Rl. In
addition we present evidence that Dsor1 is a direct activator of
Rl in vitro.
MATERIALS AND METHODS
Construction of Recombinant Expression Plasmids and Protein Ex-
pression—The entire coding region of rl and rlkd (corresponding to
rlK67M/D334N in Ref. 8) were amplified by polymerase chain reaction,
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subcloned as BamHI-EcoRI fragments into the pGEX2T vector and
expressed exactly as described for the GST fusion proteins Rl, PntP2,
PntP2T151A and Yan-A (8). Mammalian GST-MAPKK fusion protein
was provided by Sally Cowley (Chester Beatty Laboratories, London,
United Kingdom) and the pGEX1-Yan-A construct was provided by
Gerry Rubin (University of California, Berkeley, CA) (13).
Wild-type and mutant forms of rl were cloned as Asp718-EcoRI frag-
ments into the mammalian, SV40-based cell culture vector pMT21
(Genetics Institute). To construct pMT21-rl-myc and its mutant deriv-
atives, a polymerase chain reaction fragment was generated using a
reverse primer that deleted the natural termination codon and added
an additional sequence encoding the amino acids of the Myc epitope
(GGEQKLISEEDL) followed by a termination codon and a XhoI recog-
nition site.
Site-directed mutagenesis was performed to generate the constitu-
tively activated (Dsor1act) and kinase-defective (Dsor1kd) mutants of
Dsor1 (wild-type Dsor1 cDNA was provided by Y. Nishida, Aichi Cancer
Center Research Institute, Nagoya, Japan). To generate Dsor1act, the
oligonucleotide 59-GGTGCCCACAAATTCGTTGGCCATCTCGTCGA-
TCAGTTG-39 (antisense) was used to introduce AG to CT nucleotide
changes at positions 1755 and 1756 of the genomicDsor1DNA sequence
(GenBank sequence D 13782), altering Ser234 to a Glu codon and to
introduce AGG to CTT nucleotide changes at positions 1767–1769,
altering Ser238 to a Glu codon.
The Asp224 codon was mutated to an Ala codon to generate the
Dsor1kd mutant by introducing a single T to G nucleotide change at
position 1726 of the genomic Dsor1 DNA sequence, using the following
oligonucleotide: 59-GGAGACGCCGAAAGCACAGATCTTGAT-39 (anti-
sense). In each case the presence of the mutated sequence was con-
firmed by sequencing.
The entire coding regions of wild-type and mutant Dsor1 cDNA
fragments were amplified by polymerase chain reaction, using a primer
containing a 59-BamHI recognition sequence, and subcloned as BamHI
fragments into the T7 promotor-containing pET3a expression vector
(14). For protein expression, these plasmids were transformed into the
Escherichia coli strain Bl21 (DE3) PLysS, and the recombinant proteins
were expressed and purified as described (15, 16).
Transient Transfections of COS-1 Cells—COS-1 cells were grown in
Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10%
fetal calf serum. Transfections were carried out as described previously
(17). In brief, transient transfections were performed by the DEAE-
dextran method, and cells were starved in serum-free DMEM 16 h
before harvesting. Where indicated, cells were stimulated with EGF (10
ng/ml) for 10 min immediately prior to cell harvesting. Cells were
washed twice in ice-cold Tris-buffered saline, scraped off the plate, and
lysed for 10 min on ice in 20 mM Tris (pH 8), 40 mM Na4P2O7, 50 mM
NaF, 5 mM MgCl2, 100 mM Na3VO4, 10 mM EGTA, 1% Triton X-100,
0.5% sodium deoxycholate, 20 mg/ml aprotinin, and 3 mM phenylmeth-
ylsulfonyl fluoride (S buffer). Cells were centrifuged for 10 min at 4 °C,
and supernatants were stored at 270 °C.
Determination of MAPK Activation—40 mg of protein from each
COS-1 cell lysate was subjected to SDS-polyacrylamide gel electro-
phoresis and Western blotting to detect the slow-migrating, phospho-
rylated form of MAPK. In detail, after electrophoresis proteins were
transferred to nitrocellulose, blots were blocked in 5% nonfat dried milk
in TBST (10 mM Tris (pH 7.5), 150 mM NaCl, and 0.05% Tween 20) for
1 h and then probed with 9E10 monoclonal antibody (BAbCO), diluted
1:3000 in blocking buffer, for 1 h. After washing in TBST and incubat-
ing with goat anti-mouse serum coupled with horseradish peroxidase
(diluted 1:15000 in TBST), for 1 h, the blots were washed extensively
and developed using the ECL detection system (Amersham Corp.).
Determination of MAPK Activity—COS-1 cells were transfected with
wild-type and mutant Rl constructs, serum deprived, EGF stimulated,
and lysed as described above. The lysates, containing equal amounts of
MAPK protein, were incubated for 1.5 h at 4 °C with rotation in the
presence of monoclonal antibody 9E10 prebound to protein G Sepharose
beads (Sigma). The beads were washed two times with S buffer (without
phenylmethylsulfonyl fluoride), once with 30 mM Tris (pH 8), and once
with kinase buffer (30 mM Tris (pH 8), 20 mM MgCl2, and 2 mM MnCl2).
Each immunoprecipitate was incubated for 30 min at 30 °C in kinase
buffer containing 10 mM unlabeled ATP, 7.5 mg of MBP and 5 mCi of
[g-32P]ATP, and the reactions were terminated by adding SDS-poly-
acrylamide gel electrophoresis sample buffer. Incorporation of 32P into
MBP was quantified by running the samples on 15% polyacrylamide
gels, transferring to nitrocellulose, autoradiography, scanning into a
PhosphorImager (Molecular Dynamics), and analyzing the intensity of
each band using ImageQuant Software.
To analyze MAPK activity in Drosophila larvae extracts, 20 third
instar larvae for each genotype were homogenized in S buffer and
centrifuged for 10 min at 4 °C. The extracts, split into two, were incu-
bated for 1.5 h at 4 °C with rotation in the presence of Rl-specific
polyclonal DmERKA antibody (18), precoated to protein A-Sepharose
beads (Sigma). Kinase assays on the immunoprecipitates were per-
formed as described above. Where indicated, heat shocks were applied
for 1 h at 37 °C, followed by 2 h of recovering at 25 °C prior to
homogenization.
Kinase assays with bacterially expressed recombinant Rl, Yan-A,
and mammalian MAPKK proteins were carried out as described
previously (11).
Determination of MAPKK Activity—Different combinations of wild-
type, activated, and kinase-inactive versions of recombinant Dsor1 and
Rl proteins were subjected to kinase reactions, which were carried out
essentially as described previously (11), using MBP as a substrate.
RESULTS
Generation of Activated and Kinase-negative Mutant Ver-
sions of Rl and Dsor1—To study the biochemical properties of
Rl and Dsor1, eukaryotic and bacterial expression vectors en-
coding wild-type, activated, and inactive versions of these pro-
teins were generated. A kinase-inactive version of RlSem was
generated by changing Lys67 in the putative ATP-binding site
to Met (Rlkd (kinase defective)), and a kinase-inactive Dsor1
was generated by changing Asp224 of the conserved protein
kinase motif Asp-Phe-Gly (19) to Ala (Dsor1kd).
To generate an active version of Dsor1, Ser234 and Ser238,
analogous to those sites that are phosphorylated to activate
mammalian MAPKK, were changed to Glu (Dsor1act), thus
introducing a negative charge at these sites in an attempt to
mimic phosphorylation (20, 21). The activated version of Rl,
RlSem, was identified genetically as a dominant gain-of-func-
tion mutation and was shown to result in a single amino acid
substitution (Asp3343 Asn) in kinase domain XI (8). To easily
distinguish and purify recombinant proteins, a sequence encod-
ing an epitope from the c-Myc protein, recognized by the 9E10
monoclonal antibody (22), was fused to the 39-end of wild-type
and mutant Rl coding sequences. Fig. 1 shows a schematic
diagram of the proteins analyzed in this study.
Phosphorylation and Activation of Rl in Mammalian
Cells—To investigate the biochemical properties of Rl and
RlSem, we took advantage of the well established growth factor
induction system of mammalian tissue culture and investi-
gated phosphorylation and activation of these proteins.
We transiently transfected COS-1 cells with expression vec-
tors encoding wild-type and mutant Rl, harvested from either
quiescent or EGF-stimulated cells, and subjected the corre-
sponding cell lysates to Western blot analysis using the 9E10
anti-Myc antibody. Wild-type, kinase-inactive (Rlkd), and acti-
vated (RlSem) versions of Rl were phosphorylated in lysates of
EGF-stimulated cells, as indicated by a band of reduced elec-
trophoretic mobility (Fig. 2A). This suggests that Rl is phos-
phorylated in this heterologous COS cell system in an EGF-de-
FIG. 1. Schematic drawing of wild-type and mutant Rl and
Dsor1 proteins. Roman numerals, kinase subdomains (I–XI) accord-
ing to Hanks et al. (19). The positions of the point mutations, introduced
by in vitro mutagenesis, are indicated above the boxes. Stippled boxes,
positions of the Myc epitope.
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pendent manner, presumably by endogenous MAPKK. Similar
results were obtained by immunostaining with an anti-Rl poly-
clonal antibody (DmERKA; Ref. 18), which specifically detects
Drosophila Rl and not the endogenous mammalian MAPK pro-
tein (data not shown).
To measure the activity of wild-type and mutant Rl kinases,
COS-1 cells were transfected with the corresponding constructs
and stimulated with EGF. Rl proteins were immunoprecipi-
tated from lysates of these cells, and their ability to phospho-
rylate myelin basic protein (MBP, a standard MAPK substrate)
was determined. Immunoprecipitates from cells transfected
with the empty vector or expressing the kinase-inactive mutant
(Rlkd) exhibited no MBP kinase activity. In contrast, EGF-
stimulated Rl as well as RlSem showed kinase activity, meas-
ured by incorporation of radioactive phosphate into MBP (Fig.
2B). The activated RlSem was 2–3-fold more active than wild-
type Rl on EGF stimulation, a difference that was consistently
observed in duplicate experiments and was not due to differ-
ences in the expression level of the two forms of Rl. In the
absence of EGF stimulation, RlSem exhibits a slightly higher
intrinsic kinase activity than wild-type Rl, visible only after
prolonged exposure times (see below).
To elucidate potential differences in the mode of action of Rl
and RlSem, we analyzed their activity following EGF treatment
over a more extensive time course (Fig. 3). The activation of Rl
is triphasic, with a first phase peaking at 5 min, a second phase
peaking at about 30 min, and a third broad phase with a peak
at 2 h followed by a slow decline to basal levels at 9 h after the
initial addition of EGF. For mammalian MAPK, a similar ac-
tivity was reported with a first peak at 5 min and a second peak
about 3 h after EGF treatment (23, 24). In contrast, the acti-
vation of RlSem seems to be only monophasic. The activation
reaches its peak at about 5 min and is 2–3-fold higher than Rl,
as we have shown before. Then the activity continuously de-
clines to near basal levels after 9 h. Notably, throughout this
time course, the activity of RlSem is consistently higher than
that of Rl.
Phosphorylation of Nuclear Target Proteins by Rl and
RlSem—In the experiments described above, we have examined
the kinase activity of Rl toward the artificial substrate MBP. It
is possible, however, that the rlSem mutation affects the sub-
strate specificity of MAP kinase. Therefore, we wanted to test
whether Rl and RlSem behave differently toward their natural
substrates. We have demonstrated previously that pntP2 and
yan, two genes encoding nuclear factors that, like ELK-1, be-
long to the ETS domain family of transcription factors, act
downstream of rl in the Sev pathway. We showed that wild-
type Rl phosphorylates Yan and PntP2 in vitro (11). To extend
these in vitro studies, we generated and expressed recombinant
wild-type and mutant Rl proteins fused to GST and performed
kinase assays using bacterially expressed PntP2 and Yan-A as
substrates.
Rl and RlSem were able to phosphorylate Yan (Fig. 4) and
PntP2 (data not shown) in the presence of activated mamma-
lian MAPKK (a kind gift from Sally Cowley and Chris Mar-
shall, Chester Beatty Laboratories), whereas kinase-inactive
Rlkd showed no activity. RlSem exhibited 2–3-fold higher activ-
ity toward PntP2 and Yan than Rl. This difference is similar to
that observed in assays using MBP as a substrate (Fig. 2B). It
is noteworthy here that RlSem exhibited weak intrinsic kinase
activity toward Yan that was observed in the absence of acti-
vated MAPKK (Fig. 4).
Effects of Dsor1 on Rl Activity in Vitro—So far we have
shown that mammalian MAPKK is able to phosphorylate Dro-
sophila Rl kinase in COS cells. The Drosophila homologue of
MAPKK, Dsor1, has been shown genetically to act in several
different receptor tyrosine kinase-mediated pathways in Dro-
sophila. By analogy to the function of MAPKK as a direct
activator of MAPK in vertebrates, Dsor1 is believed to act
upstream of rl. There is, however, neither genetic nor biochem-
ical evidence demonstrating that Dsor1 directly activates Rl.
FIG. 2. Rl and RlSem are phosphorylated and activated in
COS-1 cells. A, Rl, RlSem and Rlkd phosphorylation was revealed as a
shift in electrophoretic mobility in EGF-induced COS-1 cells, using
antibody 9E10 as described under “Materials and Methods.” As a con-
trol, COS-1 cells were also transfected with the empty vector. The
positions of the active (MAPK-P) and inactive MAPK are indicated. B,
MAPK was immunoprecipitated from COS cell lysates with the anti-
body 9E10, and the MBP kinase activity of the immunoprecipitates was
determined as described under “Materials and Methods.” The results
were quantified with a PhosphorImager and expressed relative to the
kinase activity of Rl (1). Similar results were obtained in four separate
experiments.
FIG. 3. Time course of MBP kinase
activation in COS cells in response to
EGF. Cells were transfected with Rl (l)
and RlSem (E), respectively, serum de-
prived, and stimulated with EGF for 5,
10, 20, and 30 min and 1, 1.5, 2, 2.5, 3, 3.5,
4, 6, and 9 h. The first (1), second (2) and
third (3) phases of Rl activity are indi-
cated. Results were quantified with a
PhosphorImager and expressed as -fold
stimulation. The data presented are rep-
resentative of five experiments, which
gave similar results.
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Therefore, we wanted to test whether Dsor1 is able to phospho-
rylate and activate Rl in vitro. We expressed bacterial fusion
proteins of a putatively activated and kinase-defective version
of Dsor1 (see above), analogous to the mutations made in mam-
malian MAPKK (21). We carried out MBP kinase assays with
bacterially expressed Dsor1 and Rl mutant versions in differ-
ent combinations. Only the activated version of Dsor1,
(Dsor1act) was able to phosphorylate and activate Rl and RlSem
in vitro (Fig. 5). Wild-type Dsor1 and kinase-inactive Dsor1
(Dsor1kd) did not exhibit any kinase activity. Experiments were
also performed using PntP2 and Yan as substrates for the
kinase assays, and similar results were obtained (data not
shown). These results demonstrate that Dsor1 directly acti-
vates Rl in vitro.
Activity of Rl- and RlSem Kinase in Drosophila Larvae Ex-
tracts—Surprised by the marginal differences in kinase activ-
ity of Rl and RlSem in vitro, considering the relatively strong
effects of this mutation in vivo, we decided to investigate bio-
chemically the activity of Rl- and RlSem kinase isolated from
Drosophila larvae. Protein extracts were prepared from larvae
of different genotypes and immunoprecipitated with a poly-
clonal Rl-specific antibody, and their MBP kinase activity was
determined. We used wild-type (1/1) larvae containing two
copies of the rl gene, rlSem/1 larvae containing one copy of rlSem
and a wild-type copy of rl and, also rlSem/rl10a larvae containing
only one copy of rlSem, since the rl10a allele represents a defi-
ciency for the entire rl locus. MAP kinase activity was detected
in all extracts (Fig. 6). RlSem/1 extracts showed 5–6-fold higher
activity and rlSem/rl10a showed 8–9-fold higher stimulation
than wild-type extracts. Wild-type and mutant kinases showed
the same kinetics. The kinase assays were linear with respect
to incubation time, the amount of immunoprecipitated protein,
and the amount of added substrate protein (data not shown).
As a control, we also heat shocked larvae of the genotype
rlD334N/1, transformants carrying the Sem mutation (8), im-
munoprecipitated Rl, and determined MBP kinase activity.
These extracts exhibited 4–5-fold higher kinase activity than
wild-type extracts, exactly matching the activity of rlSem/1
extracts.
These experiments demonstrate that the difference between
wild-type Rl and RlSem kinase activity in larvae is significantly
more pronounced than in heterologous systems. The higher
activity in rlSem/rl10a (only one copy of rlSem) than in rlSem/1
(one copy of rl and one copy of rlSem) is consistent with our
genetic data. We have shown previously that the phenotype of
rlSem is enhanced in the absence of one copy of the wild-type rl
gene (8).
To analyze the activity of endogenous Rl in larvae in which
the MAP kinase pathway was activated by upstream compo-
nents, we prepared lysates from larvae expressing activated
forms of raf (raftorY9; Ref. 25) and Sev (SevS11; 26). The larvae
were heat shocked for 1 h at 37 °C to induce ubiquitous expres-
sion of the corresponding transgenes; then Rl was immunopre-
cipitated, and MBP kinase activity was determined. On heat
shock induction, Rl, immunoprecipitated from raftorY9 and
SevS11 extracts, was 9- and 4-fold more active, respectively,
than Rl immunoprecipitated from wild-type extracts (Fig. 6).
Consistent with our genetic analysis of rlSem, it seems that the
increase in kinase activity, generated by the Sem point muta-
tion, is comparable with that generated by constitutive activa-
tion of upstream signaling molecules.
DISCUSSION
The genetic characterization of the rlSem gain-of-function
mutation demonstrated that Rl plays an essential role in var-
ious developmental pathways in Drosophila. It did not permit
insight, however, into the mechanisms by which the rlSem mu-
tation affects the biochemical properties of MAP kinase in vivo.
Here we have shown that RlSem, isolated from COS-1 cells or
bacteria, possesses only weakly enhanced intrinsic kinase ac-
tivity toward the generic substrate MBP and its natural sub-
strates PntP2 and Yan. Both, wild-type and mutant Rl proteins
are phosphorylated, and their kinase activity is stimulated by
endogenous mammalian or recombinant Drosophila MAPKK,
although phosphorylated RlSem kinase is 2–3-fold more active
FIG. 4. Phosphorylation of Yan-A by wild-type and mutant Rl
proteins in vitro. Bacterially expressed recombinant proteins were
subjected to kinase assays using Yan-A as a target. In the presence of
activated mammalian MAPKK (act.MAPKK), RlSem exhibited higher
kinase activity than wild-type Rl. The kinase-defective version, Rlkd,
showed no activity. No phosphorylation of Yan-A was observed in the
presence of activated MAPKK, only. GST protein, as a control, also
showed no kinase activity. Note that RlSem exhibited weak kinase
activity without addition of activated MAPKK.
FIG. 5. Activation of Rl by Dsor1.
Bacterially expressed recombinant wild-
type and mutant forms of Rl and Dsor1
were mixed in different combinations and
subjected to kinase assays using MBP as
a substrate. Each protein alone showed
no kinase activity (data not shown). 32P
incorporation into MBP was quantified
with a PhosphorImager and expressed as
-fold activation with respect to the kinase
activity of the GST protein. Experiments
were performed twice with identical re-
sults. WT, wild-type.
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than the wild-type Rl protein. Similar results have been re-
ported for mammalian ERK2, containing the same mutation in
the homologous position. D319N ERK2 exhibits 2-fold higher
kinase activity on EGF stimulation in comparison with wild-
type ERK2 (27). In Xenopus, injection of RlSem mRNA and also
of ERKSem mRNA (p44 MAPK carrying the corresponding D to
N exchange) into embryos was sufficient to induce the expres-
sion of brachyury (Xbra), an immediate early mesoderm re-
sponse gene (28, 29). Therefore, it appears that this point
mutation in the kinase subdomain XI has a conserved effect on
different members of the MAP kinase family.
There are a number of possibilities why RlSem is more active
on stimulation than the wild-type protein. The D334N muta-
tion in RlSem could affect the subcellular localization of the
protein and thus its accessibility to activating or inactivating
signals. However, in immunofluorescence studies we did not
observe a difference in the subcellular localization of wild-type
and mutant proteins in Drosophila imaginal discs2 or when
expressed in COS-1 cells (data not shown). Alternatively, the
enhanced kinase activity of RlSem could be due to an increased
affinity toward its physiological substrates. However, the dif-
ference in activity of RlSem kinase compared with wild-type Rl
was similar for both its natural substrates, PntP2 and Yan, and
for the artificial substrate MBP. This implies that RlSem does
not possess a noticeably altered substrate specificity. Another
explanation for the increased activity is that RlSem is inacti-
vated at a reduced rate, resulting in more persistent activity. It
has been shown that mammalian ERK2, carrying the Sem
mutation (D319N ERK2), is more resistant to the action of the
MAP kinase-specific phosphatase CL100 than wild-type MAPK
(27). The results of our time course experiments also promote
this hypothesis. We showed that the activation of Rl is triphasic
in response to EGF stimulation in COS cells. A rapid activation
occurring at 5 min, a short decline at 20 min, and a second
activation at 30 min with a minimum at 1 h is followed by a
broader wave with a peak at about 2 h after stimulation. A
similar, but only biphasic, activation was already reported for
mammalian MAPK in CCL39 cells, a hamster fibroblast cell
line, showing a fast activation at 5 min and a broader phase at
about 3 h after EGF stimulation (23, 24). In contrast, the
activation of RlSem seems to be only monophasic. It peaks at
about 5 min and then continuously declines to near basal
levels. Throughout this time course the activity of RlSem is
consistently higher than that of Rl.
It is interesting to note that the duration of MAP kinase
activation has been postulated as the determinative factor in
the decision between differentiation and proliferation in PC12
pheochromocytoma cells. Stimulation of PC12 cells with EGF
results in a transient activation of MAP kinase and induces
proliferation, whereas NGF stimulation, also mediated by the
Ras-Raf pathway, results in a persistent activation of MAP
kinase and induces neurite outgrowth (30; for review, see Ref.
31). In mutant rlSem flies, the phenotypes observed are related
to changes in differentiation, such as the excess recruitment of
R7 cells, differentiation of additional wing veins, and suppres-
sion of the differentiation of the segmented trunk region of the
embryo. RlSem does not affect the proliferation of cells, al-
though rl is clearly required for cell proliferation (32). The more
persistent activity of rlSem may preferentially trigger differen-
tiation as opposed to proliferation.
In Drosophila larval extracts the kinase activity of RlSem in
comparison with wild-type Rl is considerably higher than ob-
served in EGF-stimulated COS-1 cells or when isolated from
bacteria. In fact, the level of activity was comparable to that
observed in protein extracts of larvae expressing an activated
Sev or Raf kinase. The activity was highest in rlSem/rl10a larval
extracts (8–9-fold), in which the wild-type rl allele is missing,
corroborating genetic data showing that the phenotype of rlSem
is enhanced in the absence of the wild-type copy of the rl gene
(8). The question arises why in Drosophila extracts the differ-
ence in kinase activity of Rl and RlSem is higher than in heter-
ologous systems. It is possible that the resistance of RlSem to
inactivation by phosphatases is more pronounced in larval
extracts than in COS cells. In addition, genetic experiments
suggest that the activity of RlSem is dependent on components
acting upstream in the pathway. Sos and Ras1 act as dominant2 D. Brunner, personal communication.
FIG. 6. Kinase activity of Drosoph-
ila larvae extracts. Larvae were heat
shocked (hs) where indicated, and ex-
tracts were immunoprecipitated with
DmERKA antibody. A, MAPK activity of
the immunoprecipitates was determined
and measured as the amount of 32P incor-
porated into MBP. Activity was quanti-
fied with a PhosphorImager and ex-
pressed relative to the kinase activity of
wild-type (wt) larvae (1). 1, parental
wild-type chromosomes. These data are
representative of three separate experi-
ments. B, to confirm that equal amounts
of Rl had been immunoprecipitated from
each lysate, Western blot analyses were
performed with DmERKA polyclonal an-
tibody. Immunoprecipitates of rlSem/rl10a
extracts showed about one-half of the
amount of protein, since rl10a represents a
deficiency. Thick band above MAPK, im-
munoglobulin heavy chain.
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suppressors of the rlSem phenotype.3 In this respect the behav-
ior of rlSem differs from other gain-of-function mutations in the
Sev pathway. For instance, the recruitment of additional R7
cells in flies carrying a gain-of-function mutation in sev is not
suppressed by mutations in boss, which codes for the Sev li-
gand. The dependence of RlSem on upstream components sug-
gests that some sort of feedback loop is important in maintain-
ing RlSem activation. Here we have shown biochemically that
RlSem can respond to activating signals with increased activity,
which is consistent with the hypothesis of a positive feedback
loop. Furthermore, this feedback loop may explain how, even in
the absence of an inducing signal, the basal activity of the
signaling cascade is sufficient to activate RlSem above a thresh-
old required for eliciting certain cellular responses, such as R7
differentiation in the eye, vein formation in the wing, and
suppression of segmentation in the embryo. Therefore, the slight
increase in kinase activity may be sufficient to trigger this feed-
back loop and the activation of various differentiation pathways.
A task for the future is to prove the existence of such a
feedback loop in vivo. The genetic characterization of second
site mutations that suppress or enhance the dominant pheno-
type of the rlSem mutation should lead to the identification of
further components acting in concert with rlSem in the signal
transduction pathway.
Acknowledgments—We are grateful to Cynthia Bott and Chris
Marshall for initial help in biochemical experiments and the members
of our laboratory for stimulating discussions. We thank Damian Brun-
ner for communicating unpublished results, Patrick Faller for technical
assistance, Marı´a Domı´nguez for help with the figures, and Lindsay
MacDougall, Damian Brunner, and especially Sally Leevers for critical
reading of the manuscript. We thankWilliam Biggs and Larry Zipursky
for providing DmERKA antibody, Sally Cowley and Chris Marshall for
providing the mammalian GST-MAPKK fusion protein, Gerry Rubin for
providing the pGEX1-yan-A construct, and Yasuyoshi Nishida for pro-
viding wild-type Dsor1 cDNA.
REFERENCES
1. Marshall, C. J. (1994) Curr. Opin. Genet. & Dev. 4, 82–89
2. Nishida, E., and Gotoh, Y. (1993) Trends Biochem. Sci. 18, 128–131
3. Chen, R. H., Sarnecki, C., and Blenis, J. (1992) Mol. Cell. Biol. 12, 915–927
4. Marais, R., Wynne, J., and Treisman, R. (1993) Cell 73, 381–393
5. Janknecht, R., Ernst, W. H., Pengoud, V., and Nordheim, A. (1993) EMBO J.
12, 5097–5104
6. Hafen, E., Dickson, B., Raabe, T., Brunner, D., Oellers, N., and van der
Straten, A. (1993) Development (Suppl.) 41–46
7. Zipursky, L. S., and Rubin, G. M. (1994) Annu. Rev. Neurosci. 17, 373–397
8. Brunner, D., Oellers, N., Szabad, J., Biggs, W. H., III, Zipursky, S. L., and
Hafen, E. (1994) Cell 76, 875–888
9. Tsuda, L., Inoue, Y. H., Yoo, M. A., Mizuno, M., Hata, M., Lim, Y. M.,
Adachi-Yamada, T., Ryo, H., Masamune, Y., and Nishida, Y. (1993) Cell 72,
407–414
10. Hsu, J. C., and Perrimon, N. (1994) Genes Dev. 8, 2176–2187
11. Brunner, D., Du¨cker, K., Oellers, N., Hafen, E., Scholz, H., and Kla¨mbt, C.
(1994) Nature 370, 386–389
12. O’Neill, E. M., Rebay, I., Tjian, R., and Rubin, G. M. (1994) Cell 78, 137–147
13. Lai, Z.-C., and Rubin, G. M. (1992) Cell 70, 609–620
14. Studier, F. W., and Moffat, B. A. (1986) J. Mol. Biol. 189, 113–130
15. Oellers, N., Dehio, M., and Knust, E. (1994) Mol. & Gen. Genet. 244, 465–473
16. Kerkhoff, E., and Bister, K. (1991) Oncogene 6, 93–102
17. Howe, L. R., Leevers, S. J., Go´mez, N., Nakielny, S., Cohen, P., and Marshall,
C. J. (1992) Cell 71, 335–342
18. Biggs, W. H., and Zipursky, S. L. (1992) Proc. Natl Acad. Sci. U. S. A. 89,
6295–6299
19. Hanks, S. K., Quinn, A. M., and Hunter, T. (1988) Science 241, 42–52
20. Cowley, S., Paterson, H., Kemp, P., andMarshall, C. J. (1994) Cell 77, 841–852
21. Alessi, D. R., Saito, Y., Campbell, D. G., Cohen, P., Sitanandam, G., Rapp, U.,
Ashworth, A., Marshall, C. J., and Cowley, S. (1994) EMBO J. 13,
1610–1619
22. Evan, G. I., Lewis, G. K., Ramsey, G., and Bishop, J. M. (1985)Mol. Cell. Biol.
5, 3610–3616
23. Meloche, S., Seuwen, K., Page`s, G., and Pouysse´gur, J. (1992)Mol. Endocrinol.
6, 845–854
24. Lenormand, P., Sardet, C., Page`s, G., L’Allemain, G., Brunet, A., and
Pouysse´gur, J. (1993) J. Cell Biol. 5, 1079–1088
25. Dickson, B., Sprenger, F., Morrison, D., and Hafen, E. (1992) Nature 360,
600–603
26. Basler, K., Christen, B., and Hafen, E. (1991) Cell 64, 1069–1081
27. Bott, C. M., Thorneycroft, S. G., and Marshall, C. J. (1994) FEBS Lett. 352,
201–205
28. LaBonne, C., Burke, B., and Whitman, M. (1995) Development 121, 1475–1486
29. Umbhauer, M., Marshall, C. J., Mason, C. S., Old, R. W., and Smith, J. C.
(1995) Nature 376, 58–62
30. Traverse, S., Gomez, N., Paterson, H., Marshall, C. J., and Cohen, P. (1992)
Biochem. J. 288, 351–355
31. Marshall, C. J. (1995) Cell 80, 179–185
32. Diaz-Benjumea, F. J., and Hafen, E. (1994) Development 120, 569–5783 D. Brunner and E. Hafen, manuscript in preparation.
Biochemical Characterization of Drosophila RlSem/MAP Kinase24944
 at H
auptbibliothek Universitaet Zuerich Irchel. Bereich Forschung on Septem
ber 26, 2006 
w
w
w
.jbc.org
D
ow
nloaded from
 
